5-s-cysteinyldopamine has been researched along with Neuroblastoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aureli, C; Cassano, T; Chichiarelli, S; Cocciolo, A; d'Erme, M; Fontana, M; Francioso, A; Gaetani, S; Mancini, P; Martire, S; Masci, A; Mosca, L; Romano, A | 1 |
d'Erme, M; Lendaro, E; Marcellini, S; Moretti, S; Mosca, L; Rosei, MA | 1 |
2 other study(ies) available for 5-s-cysteinyldopamine and Neuroblastoma
Article | Year |
---|---|
5-S-cysteinyldopamine neurotoxicity: Influence on the expression of α-synuclein and ERp57 in cellular and animal models of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Biogenic Monoamines; Brain; Cell Line, Tumor; Disease Models, Animal; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Glutathione; Glutathione Disulfide; Humans; Male; Mice; Neuroblastoma; Oxidative Stress; Oxidopamine; Parkinson Disease; Protein Carbonylation; Protein Disulfide-Isomerases | 2014 |
5-S-Cysteinyl-dopamine effect on the human dopaminergic neuroblastoma cell line SH-SY5Y.
Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Humans; Neuroblastoma | 2006 |